Exhale

The official blog of the Lung Institute.

COPD and Heart Health

12 Feb 2014
| Under COPD, Related Conditions | Posted by
| 2 Comments

February is American Heart Month

Did you know that February is American Heart Month? Chronic obstructive pulmonary disease (COPD) can actually cause high blood pressure and increase your risk for heart disease. Make sure to not only talk to your doctor about lung health but also about your heart. If you’re experiencing frequent flare-ups, two or more a year, your heart could be in danger of becoming damaged.

COPD and Heart Health Explained

You probably know that COPD is the third leading cause of death in the United States but did you know that heart disease is number 1? Approximately 1 in 4 people die of heart disease each year. There is good news for people wanting to improve their heart health. Simple lifestyle choices can improve your COPD symptoms and subsequently reduce your risk for heart disease.

Tips to Keep You Heart Healthy

Follow these helpful tips from the American Heart Association for heart health. To lower your risk:

• Watch your weight.

• Quit smoking and stay away from secondhand smoke.

• Control your cholesterol and blood pressure.

• If you drink alcohol, drink only in moderation.

• Get active and eat healthy.

This February make sure to get the word out about COPD and heart health. Sometimes we get so focused on the problems with our lungs and end up neglecting other potential health threats to the body. Remember, every major organ relies on oxygen in the bloodstream and therefore is impacted by your COPD.


If you or a loved one has COPD or other lung disease and want to learn more about treatment options, contact us or call 888-745-6697.

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.